0,944  0,001  Sensitization
0,809  0,002  HIV-1 integrase (3'-Processing) inhibitor
0,770  0,005  Antioxidant
0,745  0,026  Alpha-glucosidase inhibitor
0,726  0,009  Prostaglandin dehydrogenase inhibitor
0,693  0,007  UGT1A9 substrate
0,711  0,029  Apoptosis agonist
0,701  0,020  Transcription factor NF kappa B inhibitor
0,707  0,029  Antiinflammatory
0,669  0,002  HIV-1 integrase (Strand Transfer) inhibitor
0,668  0,006  Free radical scavenger
0,696  0,039  DNA polymerase beta inhibitor
0,640  0,002  Expectorant
0,649  0,013  Antibacterial
0,641  0,010  CTGF expression inhibitor
0,668  0,040  DNA directed DNA polymerase inhibitor
0,619  0,004  Lipid peroxidase inhibitor
0,619  0,016  Respiratory analeptic
0,612  0,008  UGT1A6 substrate
0,602  0,019  Aldehyde oxidase inhibitor
0,570  0,013  Histamine release inhibitor
0,567  0,010  Antiprotozoal (Leishmania)
0,565  0,012  Lipoxygenase inhibitor
0,555  0,013  Antifungal
0,559  0,018  Stroke treatment
0,550  0,020  Carcinogenic
0,545  0,019  CYP1A2 substrate
0,542  0,018  Mutagenic
0,533  0,018  12-Lipoxygenase inhibitor
0,533  0,023  Antihypercholesterolemic
0,549  0,044  Antineoplastic (breast cancer)
0,521  0,018  AR expression inhibitor
0,509  0,018  NOS2 expression inhibitor
0,508  0,018  Antimycobacterial
0,483  0,024  Analeptic
0,462  0,020  ICAM1 expression inhibitor
0,457  0,020  Hypoglycemic
0,475  0,041  5 Hydroxytryptamine release inhibitor
0,442  0,015  Myocardial infarction treatment
0,433  0,007  Protein-tyrosine phosphatase inhibitor
0,462  0,044  CYP2C9 substrate
0,435  0,032  Cardioprotectant
0,435  0,035  FMO1 substrate
0,416  0,020  Antihypertriglyceridemic
0,409  0,013  Dual specificity phosphatase 3 inhibitor
0,450  0,061  TNF expression inhibitor
0,417  0,030  Antituberculosic
0,452  0,066  Cyclophilin D inhibitor
0,452  0,066  Antidiabetic
0,419  0,034  Cytotoxic
0,397  0,012  Carcinogenic, group 3
0,406  0,023  Antidiabetic symptomatic
0,377  0,006  Protein-tyrosine phosphatase 1B inhibitor
0,425  0,056  CYP3A4 substrate
0,408  0,041  Hepatic disorders treatment
0,375  0,017  Dual specificity phosphatase inhibitor
0,406  0,048  Cholesterol antagonist
0,385  0,028  Antihypoxic
0,381  0,031  Antipyretic
0,361  0,013  Monophenol monooxygenase inhibitor
0,389  0,042  Radioprotector
0,356  0,015  Skin whitener
0,343  0,003  Plasminogen activator inhibitor antagonist
0,369  0,038  Cytostatic
0,383  0,069  Antileukemic
0,330  0,021  UGT2B7 substrate
0,352  0,055  Apoptosis antagonist
0,334  0,037  Chemopreventive
0,308  0,012  Phospholipase A2 inhibitor
0,320  0,024  Hepatoprotectant
0,332  0,044  Proliferative diseases treatment
0,285  0,004  Aldehyde dehydrogenase substrate
0,295  0,018  UGT2B15 substrate
0,310  0,033  UDP-glucuronosyltransferase substrate
0,294  0,018  Genotoxic
0,328  0,053  Aryl hydrocarbon receptor agonist
0,304  0,040  Nitric oxide antagonist
0,321  0,059  CYP2C19 substrate
0,265  0,006  Estrogen receptor beta antagonist
0,290  0,035  UGT1A1 substrate
0,303  0,048  Hypolipemic
0,264  0,013  Antineoplastic antibiotic
0,256  0,006  NAD(P)H dehydrogenase (quinone) inhibitor
0,280  0,031  Antimutagenic
0,254  0,005  TRPA1 agonist
0,269  0,022  Protein kinase stimulant
0,248  0,007  Mucolytic
0,259  0,018  UGT2B9 substrate
0,250  0,016  5-Lipoxygenase inhibitor
0,363  0,129  Antineoplastic (solid tumors)
0,301  0,068  Lipoprotein disorders treatment
0,247  0,015  Cystathionine beta-synthase inhibitor
0,259  0,028  Antiseptic
0,238  0,008  Porphobilinogen synthase inhibitor
0,311  0,082  Bone diseases treatment
0,253  0,024  Antiviral (Influenza A)
0,243  0,016  Gout treatment
0,292  0,065  UGT2B4 substrate
0,233  0,010  Estrogen antagonist
0,237  0,014  Xanthine oxidase inhibitor
0,282  0,060  Antineoplastic (renal cancer)
0,330  0,111  15-Lipoxygenase inhibitor
0,244  0,026  Phospholipase C inhibitor
0,237  0,021  Antifungal enhancer
0,220  0,004  HIV-1 integrase inhibitor
0,223  0,007  Aromatase inhibitor
0,256  0,044  Antiviral (Influenza)
0,232  0,021  Aldehyde dehydrogenase inhibitor
0,239  0,030  Melanin inhibitor
0,224  0,015  Arachidonic acid antagonist
0,222  0,014  Alcohol dehydrogenase substrate
0,264  0,058  DNA synthesis inhibitor
0,289  0,084  Caspase 3 stimulant
0,251  0,048  Wound healing agent
0,205  0,005  Antihypermotility
0,243  0,043  Neurotrophic factor enhancer
0,227  0,033  Interferon gamma antagonist
0,214  0,022  Neurotrophic factor
0,237  0,047  Pneumotoxic
0,269  0,080  Antiosteoporotic
0,213  0,024  Antihyperlipoproteinemic
0,257  0,069  Antineoplastic (liver cancer)
0,231  0,042  Mcl-1 antagonist
0,238  0,054  VCAM1 expression inhibitor
0,225  0,053  Peroxidase inhibitor
0,209  0,038  MAO inhibitor
0,235  0,067  Antihypotensive
0,271  0,107  Sodium/bile acid cotransporter inhibitor
0,177  0,015  Antibiotic
0,177  0,015  Histidine decarboxylase inhibitor
0,226  0,068  RNA-directed DNA polymerase inhibitor
0,236  0,078  Antiamyloidogenic
0,246  0,087  Chemoprotective
0,177  0,029  MAO B inhibitor
0,318  0,175  Caspase 9 stimulant
0,150  0,007  Purinergic P2X1 antagonist
0,153  0,011  Purinergic P2X2 antagonist
0,215  0,080  Antiviral (HIV)
0,220  0,085  Teratogen
0,148  0,014  HIV-1 reverse transcriptase inhibitor
0,140  0,007  Maillard reaction inhibitor
0,235  0,103  Immunostimulant
0,133  0,004  Glucose-6-phosphate translocase inhibitor
0,219  0,090  Antineoplastic (cervical cancer)
0,157  0,028  Papain-like protease (SARS coronavirus) inhibitor
0,144  0,019  Phosphofructokinase-1 inhibitor
0,138  0,014  Estrogen receptor alpha antagonist
0,165  0,042  DNA polymerase I inhibitor
0,294  0,173  Alzheimer's disease treatment
0,163  0,044  Toll-Like receptor 2 antagonist
0,196  0,077  Insulin sensitizer
0,142  0,023  Actinic keratosis treatment
0,219  0,101  DNA damaging
0,165  0,047  Acetylcholinesterase inhibitor
0,156  0,039  Topoisomerase I inhibitor
0,147  0,030  Sulfotransferase substrate
0,165  0,050  Alkaline phosphatase inhibitor
0,138  0,023  Interleukin 1 beta converting enzyme inhibitor
0,264  0,151  Antiprotozoal
0,211  0,098  Acute neurologic disorders treatment
0,212  0,100  Vascular (periferal) disease treatment
0,154  0,043  Cholesterol synthesis inhibitor
0,220  0,114  Antidiabetic (type 2)
0,132  0,026  Carbonic anhydrase XIII inhibitor
0,172  0,067  UGT1A3 substrate
0,125  0,022  Ornithine decarboxylase inhibitor
0,106  0,005  Acetyl-CoA transferase 2 inhibitor
0,165  0,064  Acaricide
0,175  0,074  Succinate dehydrogenase inhibitor
0,158  0,060  Antineoplastic (squamous cell carcinoma)
0,137  0,039  Protein kinase (CK2) inhibitor
0,151  0,054  Alpha-N-acetylglucosaminidase inhibitor
0,196  0,099  Antiglaucomic
0,191  0,095  Antiulcerative
0,109  0,014  Neuraminidase (influenza) inhibitor
0,154  0,061  Mannose-6-phosphate isomerase inhibitor
0,206  0,114  Spasmolytic
0,182  0,091  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,219  0,130  NOS3 expression inhibitor
0,156  0,067  Antiischemic, cerebral
0,227  0,140  Antineoplastic (lung cancer)
0,146  0,059  Cyclooxygenase 1 inhibitor
0,090  0,005  Adenine nucleotide translocase inhibitor
0,130  0,046  Photosensitizer
0,113  0,029  Antiviral (Trachoma)
0,182  0,099  Embryotoxic
0,150  0,071  Movement disorders treatment
0,122  0,044  Beta glucuronidase inhibitor
0,103  0,025  Prostaglandin-E synthase inhibitor
0,142  0,065  Ca2+-transporting ATPase inhibitor
0,082  0,005  Pregnane X receptor antagonist
0,221  0,148  GST M1-1 substrate
0,129  0,055  Skin irritative effect
0,148  0,075  NOS3 expression enhancer
0,093  0,022  Antitreponemal
0,119  0,048  Antischistosomal
0,091  0,022  Peroxisome proliferator-activated receptor gamma antagonist
0,235  0,167  Antineoplastic (small cell lung cancer)
0,088  0,020  Neuraminidase inhibitor
0,143  0,076  Cyclooxygenase inhibitor
0,162  0,096  Antihelmintic
0,103  0,037  Topoisomerase II alpha inhibitor
0,107  0,042  Androgen antagonist
0,127  0,062  Topoisomerase II inhibitor
0,224  0,160  Vasodilator, coronary
0,205  0,141  5 Hydroxytryptamine uptake stimulant
0,155  0,092  UGT2B10 substrate
0,094  0,032  GABA aminotransferase inhibitor
0,149  0,087  UGT1A4 substrate
0,111  0,049  Anabolic
0,114  0,054  UGT2B1 substrate
0,157  0,097  Diabetic nephropathy treatment
0,129  0,073  Antiacne
0,179  0,123  Vasodilator
0,198  0,143  Prostate cancer treatment
0,111  0,058  MAO A inhibitor
0,219  0,167  GST A substrate
0,062  0,009  DNA gyrase subunit A inhibitor
0,171  0,118  Antineoplastic (glioma)
0,102  0,050  Uric acid excretion stimulant
0,092  0,040  Macrophage migration inhibitory factor inhibitor
0,166  0,115  Antiparasitic
0,071  0,021  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,136  0,090  Heat shock protein 90 antagonist
0,124  0,079  Antihemorrhagic
0,103  0,058  UDP-glucose 4-epimerase inhibitor
0,122  0,077  Cyclooxygenase 2 inhibitor
0,156  0,113  Antirickettsial
0,191  0,150  Radiosensitizer
0,083  0,042  Glutamate dehydrogenase inhibitor
0,183  0,143  Antineoplastic (pancreatic cancer)
0,082  0,043  SULT1A2 substrate
0,055  0,017  Neuraminidase (Influenza A) inhibitor
0,065  0,028  Estrogen agonist
0,125  0,089  Antieczematic
0,053  0,019  Estrogen receptor beta agonist
0,088  0,055  Granulocyte macrophage colony stimulating factor agonist
0,065  0,035  Xanthine dehydrogenase inhibitor
0,075  0,046  Glycine receptor agonist
0,072  0,042  Potassium channel large-conductance Ca-activated activator
0,039  0,010  Glutamate (mGluR3) agonist
0,061  0,032  Aldose reductase inhibitor
0,091  0,063  Alcohol dehydrogenase inhibitor
0,174  0,146  Antineoplastic (ovarian cancer)
0,062  0,035  Bcl-xL inhibitor
0,185  0,157  Antiischemic
0,064  0,039  Antimycoplasmal
0,044  0,020  Retinoic acid alpha receptor agonist
0,144  0,120  Anesthetic general
0,076  0,054  Keratolytic
0,052  0,031  CD45 antagonist
0,197  0,175  Thioredoxin glutathione reductase inhibitor
0,139  0,117  DNA methyltransferase I inhibitor
0,123  0,102  SULT1A3 substrate
0,099  0,078  DOPA decarboxylase inhibitor
0,099  0,079  Chelator
0,030  0,011  Peroxisome proliferator-activated receptor alpha antagonist
0,218  0,199  Atherosclerosis treatment
0,064  0,046  Leukotriene antagonist
0,124  0,107  Eye irritation, high
0,035  0,019  Catechol O-methyltransferase inhibitor
0,024  0,010  Retinoic acid alpha receptor antagonist
0,105  0,092  Amylase inhibitor
0,084  0,072  Paget's disease treatment
0,118  0,108  Antidote
0,023  0,014  Estrone sulfatase inhibitor
0,218  0,210  CYP2C19 inhibitor
0,088  0,080  UGT2B11 substrate
0,034  0,028  Nicotinic acid receptor 2 agonist
0,068  0,062  Na+ K+ transporting ATPase inhibitor
0,019  0,013  Retinoic acid receptor antagonist
0,022  0,018  Retinoic acid receptor agonist
0,266  0,262  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,072  0,069  Xanthine oxidase substrate
0,012  0,009  Retinoic acid beta receptor antagonist
0,039  0,036  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,011  0,009  Retinoic acid receptor gamma antagonist
0,047  0,045  Alpha tubulin antagonist
0,036  0,035  Estradiol 17 beta-dehydrogenase inhibitor

